These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 33519770)

  • 1. Inactivation Effect of Violet and Blue Light on ESKAPE Pathogens and Closely Related Non-pathogenic Bacterial Species - A Promising Tool Against Antibiotic-Sensitive and Antibiotic-Resistant Microorganisms.
    Hoenes K; Bauer R; Meurle T; Spellerberg B; Hessling M
    Front Microbiol; 2020; 11():612367. PubMed ID: 33519770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of violet and blue light irradiation on ESKAPE pathogens and human cells in presence of cell culture media.
    Bauer R; Hoenes K; Meurle T; Hessling M; Spellerberg B
    Sci Rep; 2021 Dec; 11(1):24473. PubMed ID: 34963696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation on Potential ESKAPE Surrogates for 222 and 254 nm Irradiation Experiments.
    Gierke AM; Hessling M
    Front Microbiol; 2022; 13():942708. PubMed ID: 35847114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterizing the Antimicrobial Properties of 405 nm Light and the Corning® Light-Diffusing Fiber Delivery System.
    Shehatou C; Logunov SL; Dunman PM; Haidaris CG; Klubben WS
    Lasers Surg Med; 2019 Dec; 51(10):887-896. PubMed ID: 31302937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Photodynamic Inactivation of ESKAPE Group Bacterial Pathogens in Planktonic and Biofilm Cultures Using Metallated Porphyrin-Doped Conjugated Polymer Nanoparticles.
    Martínez SR; Ibarra LE; Ponzio RA; Forcone MV; Wendel AB; Chesta CA; Spesia MB; Palacios RE
    ACS Infect Dis; 2020 Aug; 6(8):2202-2213. PubMed ID: 32538610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Photoinactivation of Staphylococci with 405 nm Light in a Trachea Model with Saliva Substitute at 37 °C.
    Meurle T; Knaus J; Barbano A; Hoenes K; Spellerberg B; Hessling M
    Healthcare (Basel); 2021 Mar; 9(3):. PubMed ID: 33799642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Celecoxib Enhances the Efficacy of Low-Dose Antibiotic Treatment against Polymicrobial Sepsis in Mice and Clinical Isolates of ESKAPE Pathogens.
    Annamanedi M; Varma GYN; Anuradha K; Kalle AM
    Front Microbiol; 2017; 8():805. PubMed ID: 28533769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alternatives for the treatment of infections caused by ESKAPE pathogens.
    da Rosa TF; Coelho SS; Foletto VS; Bottega A; Serafin MB; Machado CS; Franco LN; de Paula BR; Hörner R
    J Clin Pharm Ther; 2020 Aug; 45(4):863-873. PubMed ID: 32339305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantifying the Evolutionary Conservation of Genes Encoding Multidrug Efflux Pumps in the ESKAPE Pathogens To Identify Antimicrobial Drug Targets.
    Brooks LE; Ul-Hasan S; Chan BK; Sistrom MJ
    mSystems; 2018; 3(3):. PubMed ID: 29719870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibacterial activity of medicinal plants against ESKAPE: An update.
    Bhatia P; Sharma A; George AJ; Anvitha D; Kumar P; Dwivedi VP; Chandra NS
    Heliyon; 2021 Feb; 7(2):e06310. PubMed ID: 33718642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Light Modulates Important Pathogenic Determinants and Virulence in ESKAPE Pathogens Acinetobacter baumannii, Pseudomonas aeruginosa, and Staphylococcus aureus.
    Tuttobene MR; Pérez JF; Pavesi ES; Perez Mora B; Biancotti D; Cribb P; Altilio M; Müller GL; Gramajo H; Tamagno G; Ramírez MS; Diacovich L; Mussi MA
    J Bacteriol; 2021 Feb; 203(5):. PubMed ID: 33288627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Photoinactivation of ESKAPE pathogens: overview of novel therapeutic strategy.
    Nakonieczna J; Wozniak A; Pieranski M; Rapacka-Zdonczyk A; Ogonowska P; Grinholc M
    Future Med Chem; 2019 Mar; 11(5):443-461. PubMed ID: 30901231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bactericidal efficacy of atmospheric pressure non-thermal plasma (APNTP) against the ESKAPE pathogens.
    Flynn PB; Higginbotham S; Alshraiedeh NH; Gorman SP; Graham WG; Gilmore BF
    Int J Antimicrob Agents; 2015 Jul; 46(1):101-7. PubMed ID: 25963338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An overview of resistance profiles ESKAPE pathogens from 2010-2015 in a tertiary respiratory center in Romania.
    Peneş NO; Muntean AA; Moisoiu A; Muntean MM; Chirca A; Bogdan MA; Popa MI
    Rom J Morphol Embryol; 2017; 58(3):909-922. PubMed ID: 29250670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Photodynamic therapy for ESKAPE pathogens: An emerging approach to combat antimicrobial resistance (AMR).
    Mathur A; Parihar AS; Modi S; Kalra A
    Microb Pathog; 2023 Oct; 183():106307. PubMed ID: 37604213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of ESKAPE Bacterial Pathogens at the Point of Care Using Isothermal DNA-Based Assays in a Portable Degas-Actuated Microfluidic Diagnostic Assay Platform.
    Renner LD; Zan J; Hu LI; Martinez M; Resto PJ; Siegel AC; Torres C; Hall SB; Slezak TR; Nguyen TH; Weibel DB
    Appl Environ Microbiol; 2017 Feb; 83(4):. PubMed ID: 27986722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-thermal Plasma Treatment of ESKAPE Pathogens: A Review.
    Scholtz V; Vaňková E; Kašparová P; Premanath R; Karunasagar I; Julák J
    Front Microbiol; 2021; 12():737635. PubMed ID: 34712211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bacteremia due to ESKAPE pathogens: An emerging problem in cancer patients.
    El-Mahallawy HA; Hassan SS; El-Wakil M; Moneer MM
    J Egypt Natl Canc Inst; 2016 Sep; 28(3):157-62. PubMed ID: 27268592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retrospective Analysis on Antimicrobial Resistance Trends and Prevalence of β-lactamases in
    Nasser M; Palwe S; Bhargava RN; Feuilloley MGJ; Kharat AS
    Microorganisms; 2020 Oct; 8(10):. PubMed ID: 33096921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Considerations and Caveats in Combating ESKAPE Pathogens against Nosocomial Infections.
    Ma YX; Wang CY; Li YY; Li J; Wan QQ; Chen JH; Tay FR; Niu LN
    Adv Sci (Weinh); 2020 Jan; 7(1):1901872. PubMed ID: 31921562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.